SignatureFD’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.37K | Buy |
2,720
+427
| +19% | +$530 | ﹤0.01% | 2705 |
|
|
2025
Q1 | $2.71K | Sell |
2,293
-2,161
| -49% | -$2.55K | ﹤0.01% | 2785 |
|
|
2024
Q4 | $8.15K | Sell |
4,454
-173
| -4% | -$317 | ﹤0.01% | 2429 |
|
|
2024
Q3 | $7.87K | Buy |
4,627
+2,870
| +163% | +$4.88K | ﹤0.01% | 2425 |
|
|
2024
Q2 | $2.41K | Buy |
1,757
+1,095
| +165% | +$1.5K | ﹤0.01% | 2709 |
|
|
2024
Q1 | $2.48K | Buy |
662
+189
| +40% | +$709 | ﹤0.01% | 2739 |
|
|
2023
Q4 | $4.64K | Buy |
473
+155
| +49% | +$1.52K | ﹤0.01% | 2515 |
|
|
2023
Q3 | $2.66K | Hold |
318
| – | – | ﹤0.01% | 2694 |
|
|
2023
Q2 | $4.23K | Hold |
318
| – | – | ﹤0.01% | 2569 |
|
|
2023
Q1 | $3.68K | Sell |
318
-61
| -16% | -$706 | ﹤0.01% | 2621 |
|
|
2022
Q4 | $3.1K | Hold |
379
| – | – | ﹤0.01% | 2651 |
|
|
2022
Q3 | $2K | Buy |
379
+83
| +28% | +$438 | ﹤0.01% | 2817 |
|
|
2022
Q2 | $1K | Sell |
296
-222
| -43% | -$750 | ﹤0.01% | 2967 |
|
|
2022
Q1 | $5K | Buy |
518
+457
| +749% | +$4.41K | ﹤0.01% | 2486 |
|
|
2021
Q4 | $1K | Sell |
61
-108
| -64% | -$1.77K | ﹤0.01% | 2963 |
|
|
2021
Q3 | $4K | Buy |
+169
| New | +$4K | ﹤0.01% | 2448 |
|
|
2021
Q2 | – | Sell |
-17
| Closed | -$1K | – | 3003 |
|
|
2021
Q1 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 2648 |
|
|
2020
Q1 | – | Sell |
-247
| Closed | -$1K | – | 2387 |
|
|
2019
Q4 | $1K | Buy |
+247
| New | +$1K | ﹤0.01% | 2064 |
|